SCHEMBL9707463

SCHEMBL9707463

Cn1c(=O)[nH]c2nc(C3CCCCC3)n(Cc3ccc(-c4ccccc4-c4nnn[nH]4)cc3)c2c1=O

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
AGTR1 P30556 5/20 0.42
AGTR2 P50052 4/20 0.42
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK1 P28482 2/20 0.38
BLM P54132 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
GPR18 Q14330 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708115 0.92 KMT2A (0.42) KMT2AAGTR1AGTR2POLBMEN1
SCHEMBL9709026 0.91 KMT2A (0.43) KMT2AAGTR1AGTR2POLBMEN1
SCHEMBL9708761 0.91 ADORA3 (0.43) KMT2AAGTR1AGTR2PPARG
SCHEMBL9708395 0.91 KMT2A (0.42) KMT2AAGTR1AGTR2PPARG
SCHEMBL9707737 0.90 KMT2A (0.43) KMT2AAGTR1AGTR2POLBMEN1
SCHEMBL9708511 0.89 KMT2A (0.41) KMT2AAGTR1AGTR2POLBMEN1
SCHEMBL9707300 0.89 AGTR1 (0.39) KMT2AAGTR1AGTR2GPR18PPARG
SCHEMBL9707895 0.89 KMT2A (0.41) KMT2AAGTR1AGTR2MEN1PPARG
SCHEMBL9707731 0.89 AGTR1 (0.41) KMT2AAGTR1AGTR2MEN1PPARG
SCHEMBL9708489 0.89 AGTR1 (0.41) KMT2AAGTR1AGTR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO claimed
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed